angiotensin ii human

Angiotensin II human acetate 是肾素-血管紧张素系统中的主要血管收缩肽，通过与AT1R和AT2R受体结合调节血压，刺激交感神经，促进醛固酮合成和肾脏功能，诱导血管平滑肌细胞增生和胶原合成，导致血管及心肌增厚和纤维化，同时促进细胞凋亡和内皮毛细血管形成。常用于诱导高血压和心脏肥大模型。

Angiotensin II 是一种主要的生物活性血管收缩肽，通过与AT1R和AT2R受体结合，调节血压，刺激交感神经，促进醛固酮合成和肾脏功能。它还能诱导血管平滑肌细胞增生、胶原合成增加，导致血管和心肌增厚及纤维化，同时促进细胞凋亡和内皮细胞毛细血管形成。Angiotensin II常用于诱导高血压和心脏肥大动物模型。

Angiotensin II human TFA 是肾素-血管紧张素系统中的强效血管收缩剂，通过与 AT1R 和 AT2R 受体作用调节血压，可激活交感神经、促进醛固酮合成和肾功能，诱导血管平滑肌细胞增殖及成纤维细胞中 I 型和 III 型胶原合成，导致血管和心肌增厚、纤维化，并诱导凋亡及促进毛细血管生成，可用于构建心脏肥大、高血压和腹主动脉瘤模型。

Angiotensin II (3-8), human (TFA) is an angiotensin AT1 receptor agonist with less activity.

Angiotensin II (5-8) is an endogenous C-terminal fragment of the peptide vasoconstrictor angiotensin II

Angiotensin II is a potent direct vasoconstrictor, causing arteries and veins to constrict, so leading to an increase in blood pressure. Angiotensin also potentiates the release of norepinephrine by a direct action on postganglionic sympathetic fibers.

Angiotensin II is a potent direct vasoconstrictor, causing arteries and veins to constrict, so leading to an increase in blood pressure.

CAY10434是一种有作用的 CYP4A 羟化酶 (CYP4A hydroxylase) 抑制剂，在人肾微粒体测试中的 IC50值为8.8 nM。CAY 10434 在改善血管紧张素 II 的收缩过程中 Emax 为 6764 mg。

Angiotensin I-13C6,15N (human, mouse, rat) TFA 是经过13C 和15N 标记的蛋白质,具体为Angiotensin I (human, mouse, rat) TFA 的同位素标记形式。此化合物作为angiotensin II的前体，在血管紧张素转化酶 (ACE) 的作用下被裂解, 产生angiotensin II。

Eprosartan (SKF-108566J free base) 是一种具有选择性和竞争性的非肽类血管紧张素II受体拮抗剂，对AT1受体亚型具有高亲和力，可用作降压剂。Eprosartan 对血管紧张素 II 受体有抑制作用，在大鼠和人类肾上腺皮质膜中的 IC50 值分别为 9.2 nM 和 3.9 nM。

Losartan Carboxylic Acid (E-3174) 是 Losartan 的活性羧酸代谢产物，是血管紧张素Ⅱ受体 1 型(AT1)拮抗剂。它能够阻断血管紧张素 II 诱导的血管平滑肌细胞反应，可以提高血浆肾素活性，降低平均动脉压。

4-hydroxy Valsartan is a major metabolite of the angiotensin II type 1 (AT1) receptor antagonist valsartan . It reduces platelet aggregation induced by epinephrine and collagen but not ADP in human whole blood.

Telmisartan acyl-β-D-glucuronide is a major metabolite of the angiotensin II receptor antagonist telmisartan . It does not bind human serum albumin and is cleared from rat plasma with a clearance rate of 180 ml min kg following intravenous administration.

Prostaglandin A1 (PGA1) was first isolated as a dehydration product of the PGE1 compounds found in human semen. 15-keto PGA1 is a metabolite of PGA1, produced by 15-hydroxy PG dehydrogenase. It can be produced from PGA1 in pig lung, trachea, aorta, and pulmonary artery tissue preparations. 15-keto PGA1, given at a concentration of 6 μM, causes vasoconstriction of rabbit lung that is comparable to that induced by angiotensin II.

Angiotensin II (3-8), human 是活性稍弱的血管紧张素AT1受体激动剂。

AT2R antagonist 1 是一种高度选择性的、有效的 AT2R (血管紧张素 II AT2 受体)配体。AT2R antagonist 1 能够高度亲和 AT2R 亲和力 (Ki: 29 nM)。AT2R antagonist 1 能够抑制常见的药物代谢CYP 酶，在人、大鼠和小鼠肝微粒体中具有较高的稳定性。

Angiotensin III, human, mouse (Angiotensin III, human, mouse(3TFA)) 是一种七肽，是血管紧张素 2 型受体 (AT2R) 激动剂，能够作用于 AT2R (IC50:0.648 nM)及 AT1R (IC50:21.1nM)。

Safflor yellow B 通过抑制血管紧张素 II 介导的人脐静脉细胞损伤，调节 Bcl-2 p22 (phox) 表达，展现出神经保护作用。

18-Hydroxy-11-deoxy Corticosterone (18-OH-DOC) is a mineralocorticoid produced by the zona fasciculata of the adrenal gland, with its biosynthesis regulated by adrenocorticotropic hormone (ACTH) and angiotensin II. This regulation heightens 18-OH-DOC production in isolated human adrenal glomerulosa cells and allows for its formation from 11-deoxy corticosterone (DOC) in human SK-MEL188 melanoma cells. As an intermediate in progesterone metabolism, 18-OH-DOC can be converted to aldosterone in rat adrenal glands' capsular portion. Its continuous infusion (200 μg rat per day) has been shown to raise systolic blood pressure in uninephrectomized saline-drinking rats, and elevated plasma levels of 18-OH-DOC have been observed in the adb db mouse model of type 2 diabetes.

Angiotensin I (human, mouse, rat) 是血管紧张素Ⅱ的前体物质，在血管紧张素转化酶 (ACE) 的参与下裂解成血管紧张素Ⅱ。